Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10118963 Antigen binding proteins that bind PD-L1

Patent 10118963 was granted and assigned to Sorrento Therapeutics on November, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 12 Mar, 2024

"update inverses"

edited on 12 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11919952 Antigen binding proteins that bind PD-L1

0

Edits on 30 Jan, 2024

"update inverses"

edited on 30 Jan, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11878058 Antigen binding proteins that bind PD-L1

0

Edits on 8 Dec, 2023

"Add patent abstract"

edited on 8 Dec, 2023

Edits made to:

Article (+271 characters)

Article

Patent abstract

There is disclosed anti-PD-L1 IgG class antibodies that have an improved ability to be manufactured at higher yields. More specifically, there is disclosed human antibodies that bind PD-L1, PD-L1-binding fragments that can be manufactured at higher yields.

Edits on 11 Oct, 2023

"update inverses"

edited on 11 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11779604 Antibodies, combinations comprising antibodies, biomarkers, uses and methods

Edits on 5 Oct, 2023

"update inverses"

edited on 5 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11773175 Antibodies, uses and methods

Edits on 1 Oct, 2023

"Add patent inventor(s)"

edited on 1 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Inventor Names

Heyue Zhou0

Edits on 13 Sep, 2023

"update inverses"

edited on 13 Sep, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11753479 Nucleic acids encoding anti-OX40L antibodies

Edits on 24 Mar, 2023

"update citations for inverse infoboxes"

edited on 24 Mar, 2023

Infobox

Patent Citations Received

US Patent 11027012 Antigen binding proteins that bind PD-L1

0

Edits on 12 Feb, 2022

"update inverses"

edited on 12 Feb, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

US Patent 11027012 Antigen binding proteins that bind PD-L1

Edits on 10 Feb, 2022

"update inverses"

edited on 10 Feb, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

US Patent 10919964 Antigen binding proteins that bind PD-L1

Edits on 2 Feb, 2022

"update inverses"

edited on 2 Feb, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

US Patent 10604576 Antibodies and immunocytokines

Edits on 23 Jan, 2022

"Created via: Entity Importer"

created this topic on 23 Jan, 2022

Edits made to:

Infobox (+9 properties)

‌

US Patent 10118963 Antigen binding proteins that bind PD-L1

Infobox

Is a

Patent applicant

Sorrento Therapeutics

Current assignee

Sorrento Therapeutics

Patent jurisdiction

United States Patent and Trademark Office

Patent number

10118963

Date of patent

November 6, 2018

Patent application number

15418514

Date Filed

January 27, 2017

Patent primary examiner

Jessica H Roark

Find more entities like US Patent 10118963 Antigen binding proteins that bind PD-L1

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.